During the early stages of tauopathies, Tau exhibits specific characteristics: its expression levels increase, its soluble fraction expands, and it progressively forms oligomers and aggregates that result in neuronal damage and cell death (Kurbatskaya et al., 2016; Wang and Mandelkow, 2016; Han et al., 2017). This evidence concerns the gene MAPT and tauopathy.